-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TED-N in Acute Spinal Cord Injury
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TED-N in Acute Spinal Cord Injury report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TED-N in Acute Spinal Cord InjuryDrug Details:Stem cell therapy is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lu-AG22515 in Neuromyelitis Optica (Devic’s Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lu-AG22515 in Neuromyelitis Optica (Devic's Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lu-AG22515 in Neuromyelitis Optica (Devic's Syndrome) Drug Details: Lu-AG22515 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VRDN-002 in Graves’ Ophthalmopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VRDN-002 in Graves' Ophthalmopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VRDN-002 in Graves' Ophthalmopathy Drug Details: VRDN-002 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lu-AG22515 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lu-AG22515 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lu-AG22515 in Rheumatoid Arthritis Drug Details: Lu-AG22515 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lu-AG22515 in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lu-AG22515 in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lu-AG22515 in Systemic Lupus Erythematosus Drug Details: Lu-AG22515 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TOUR-006 in Graves’ Ophthalmopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TOUR-006 in Graves' Ophthalmopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TOUR-006 in Graves' Ophthalmopathy Drug Details: TOUR-006 is under development for thyroid...
-
Sector Analysis
Eastern Europe Foodservice Market Size and Trends by Profit and Cost Sector Channels, Players and Forecast to 2027
Eastern Europe Foodservice Market Report Overview The Eastern Europe foodservice profit sector recorded sales of $80.1 billion in 2022 and is forecast to record a strong CAGR of over 20% during 2022-2027. The Eastern European foodservice industry is witnessing a surge in the adoption of vegan and plant-based diets by consumers. Thus, plant-based menus, featuring innovative alternatives to traditional dishes are becoming increasingly popular. Additionally, restaurants and cafes across the region are increasingly adopting eco-friendly practices to minimize their environmental...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Linsitinib in Graves’ Ophthalmopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Linsitinib in Graves' Ophthalmopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Linsitinib in Graves' Ophthalmopathy Drug Details: Linsitinib (OSI906, ASP7487) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TOUR-006 in Graves’ Ophthalmopathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TOUR-006 in Graves' Ophthalmopathy Drug Details: TOUR-006 is under development for thyroid eye disease (TED) and atherosclerotic...